Patients with acute and chronic coronary syndromes have elevated long-term thrombin generation.
Acute Coronary Syndrome
/ blood
Adult
Aged
Anticoagulants
/ therapeutic use
Biomarkers
Blood Coagulation
/ drug effects
Blood Coagulation Tests
Case-Control Studies
Chronic Disease
Coronary Artery Disease
/ blood
Female
Humans
Male
Middle Aged
Platelet Aggregation Inhibitors
/ therapeutic use
Thrombin
/ metabolism
Time Factors
Up-Regulation
Acute coronary syndrome
Chronic coronary syndrome
Coronary artery disease
Peak thrombin
Thrombin generation
Velocity index
Journal
Journal of thrombosis and thrombolysis
ISSN: 1573-742X
Titre abrégé: J Thromb Thrombolysis
Pays: Netherlands
ID NLM: 9502018
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
pubmed:
23
2
2020
medline:
8
6
2021
entrez:
21
2
2020
Statut:
ppublish
Résumé
Coronary artery disease is a leading cause of morbidity and mortality worldwide. Despite significant advances in revascularization strategies and antiplatelet therapy with aspirin and/or P2Y
Identifiants
pubmed: 32077007
doi: 10.1007/s11239-020-02066-y
pii: 10.1007/s11239-020-02066-y
doi:
Substances chimiques
Anticoagulants
0
Biomarkers
0
Platelet Aggregation Inhibitors
0
Thrombin
EC 3.4.21.5
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM